At a glance

ClinicalIndex Comparison Record

Phase 2Completed· 236 enrolled

Drug / intervention

Twinrix +1 moredrug

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00316303

NCT00316303Phase 2Completed

Compare CT.gov

The STIRR Intervention for Dually Diagnosed Clients

Dartmouth-Hitchcock Medical Center·interventional·Posted Apr 20, 2006·Updated May 22, 2013

In Brief

A Phase 2 clinical trial evaluating Twinrix and Enhanced treatment as usual for HIV Infections and 5 related conditions. Completed, enrolled 236 participants across 1 site.

Detailed Summary

This study will determine the effectiveness of the STIRR (Screen, Test, Immunize, Reduce risk, and Refer) intervention in increasing rates of testing, immunization, referral, and treatment for blood-borne diseases, such as hepatitis and HIV, in people with both a mental disorder and a substance abuse disorder.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsHIV Infections, Schizophrenia, Schizoaffective Disorder, Bipolar Disorder, Depression, Substance Abuse

CountriesUnited States

CollaboratorsNational Institute of Mental Health (NIMH)

Timeline

Phase 2CompletedFinished

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Enrollment StartFeb 2006

First PostedApr 2006

Primary CompletionApr 2009

Study CompletionAug 2012

TodayJul 2026

First PostedApr 20, 2006

Enrollment StartFeb 1, 2006

Primary CompletionApr 1, 2009

Study CompletionAug 1, 2012

TodayJul 2, 2026

Enrollment to primary: 3.2 yearsPosted 20.2 years ago

Interventions

Twinrixdrug

This vaccine will be given in three parts: at entry and after 3 and 6 months.

Enhanced treatment as usualbehavioral

Participants will receive comprehensive mental health services provided at each study site, education about blood-borne diseases, and referral to a local community health provider for blood testing, HAV and HBV immunizations, and any necessary treatments.